Cellular Goods a UK-based provider of premium consumer products based on biosynthetic cannabinoids announced its intention to join the main market (standard) this spring. Target valuation £20m raising c. £8m “to finalise the development and launch of a range of the Company's premium-quality consumer products based on biosynthetic cannabinoids, which is fully compliant under UK law.” Kanabo Group (RTO by Spinnaker Opportunities SOP.L) on the main market (standard). Raising £6m, enlarged mkt cap £ ....
05 Feb 2021
Small Cap Feast
Kibo Energy Plc (KIBO:LON), 0.0 | Hargreaves Services plc (HSP:LON), 545 | Savannah Energy Plc (SAVE:LON), 26.4 | Aquis Exchange Plc (AQX:LON), 424 | Distribution Finance Capital Holdings Plc (DFCH:LON), 22.5 | Tekcapital Plc (TEK:LON), 8.2 | Ascent Resources plc (AST:LON), 2.4 | Warehouse REIT PLC (WHR:LON), 77.2 | Silence Therapeutics plc (SLNCF:OTC), 0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Small Cap Feast
Kibo Energy Plc (KIBO:LON), 0.0 | Hargreaves Services plc (HSP:LON), 545 | Savannah Energy Plc (SAVE:LON), 26.4 | Aquis Exchange Plc (AQX:LON), 424 | Distribution Finance Capital Holdings Plc (DFCH:LON), 22.5 | Tekcapital Plc (TEK:LON), 8.2 | Ascent Resources plc (AST:LON), 2.4 | Warehouse REIT PLC (WHR:LON), 77.2 | Silence Therapeutics plc (SLNCF:OTC), 0
- Published:
05 Feb 2021 -
Author:
Derren Nathan -
Pages:
6
Cellular Goods a UK-based provider of premium consumer products based on biosynthetic cannabinoids announced its intention to join the main market (standard) this spring. Target valuation £20m raising c. £8m “to finalise the development and launch of a range of the Company's premium-quality consumer products based on biosynthetic cannabinoids, which is fully compliant under UK law.” Kanabo Group (RTO by Spinnaker Opportunities SOP.L) on the main market (standard). Raising £6m, enlarged mkt cap £ ....